01 4Boehringer lngelheim Animal Health Canada Inc.
01 12161703
02 12632694
03 12684632
04 12848317
01 3ESAFOXOLANER | EPRINOMECTIN | PRAZIQUANTEL
02 1Eprinomectin
01 3SOLUTION
02 1topical solution
01 12014-04-28
02 12026-12-28
03 12028-06-20
04 12032-09-12
Patent Expiration Date : 2014-04-28
Date Granted : 2000-02-01
Brand Name : IVOMEC EPRINEX
Patent Number : 2161703
Filing Date : 1994-04-28
Strength per Unit : 5 mg/ml
Dosage Form : topical solution
Human Or VET : Veterinary
Route of Administration : Percutaneous
Patent Expiration Date : 2014-04-28
Date Granted : 2000-02-01
Patent Expiration Date : 2026-12-28
Date Granted : 2014-10-28
ESAFOXOLANER, EPRINOMECTIN, PRAZIQUANTEL
Brand Name : NEXGARD COMBO
Patent Number : 2632694
Filing Date : 2006-12-28
Strength per Unit : 1.2% w / v / 0.4% w / v / 8.3% w / v
Dosage Form : SOLUTION
Human Or VET : Veterinary
Route of Administration : TOPICAL
Patent Expiration Date : 2026-12-28
Date Granted : 2014-10-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-06-20
Date Granted : 2017-03-07
ESAFOXOLANER, EPRINOMECTIN, PRAZIQUANTEL
Brand Name : NEXGARD COMBO
Patent Number : 2684632
Filing Date : 2008-06-20
Strength per Unit : 1.2% w / v / 0.4% w / v / 8.3% w / v
Dosage Form : SOLUTION
Human Or VET : Veterinary
Route of Administration : TOPICAL
Patent Expiration Date : 2028-06-20
Date Granted : 2017-03-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-09-12
Date Granted : 2021-01-19
ESAFOXOLANER, EPRINOMECTIN, PRAZIQUANTEL
Brand Name : NEXGARD COMBO
Patent Number : 2848317
Filing Date : 2012-09-12
Strength per Unit : 1.2% w / v / 0.4% w / v / 8.3% w / v
Dosage Form : SOLUTION
Human Or VET : Veterinary
Route of Administration : TOPICAL
Patent Expiration Date : 2032-09-12
Date Granted : 2021-01-19
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
